Cite
Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
MLA
Schoots, I. G.(Ivo), and A.(Anwar) Padhani. Risk-Adapted Biopsy Decision Based on Prostate Magnetic Resonance Imaging and Prostate-Specific Antigen Density for Enhanced Biopsy Avoidance in First Prostate Cancer Diagnostic Evaluation. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1244879273&authtype=sso&custid=ns315887.
APA
Schoots, I. G. (Ivo), & Padhani, A. (Anwar). (2020). Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.
Chicago
Schoots, I.G. (Ivo), and A. (Anwar) Padhani. 2020. “Risk-Adapted Biopsy Decision Based on Prostate Magnetic Resonance Imaging and Prostate-Specific Antigen Density for Enhanced Biopsy Avoidance in First Prostate Cancer Diagnostic Evaluation.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1244879273&authtype=sso&custid=ns315887.